Evidence map›Paper›PMID 36834479›Full record

ArticleInternational journal of molecular sciences2023

The Search of Association of HLA Class I and Class II Alleles with COVID-19 Mortality in the Russian Cohort.

Valery Cheranev, Irina Bulusheva, Valery Vechorko, Dmitriy Korostin, Denis Rebrikov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Narrative Review Explaining the Role ofInfectious disease reports · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Valery CheranevCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.ORCID 0000-0001-5294-3033
Irina BulushevaCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.ORCID 0000-0001-8980-8425
Valery VechorkoCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.
Dmitriy KorostinCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.ORCID 0000-0003-1343-2550
Denis RebrikovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova Street, 117997 Moscow, Russia.ORCID 0000-0002-1884-1807
Pirogov Russian National Research Medical University · RU

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1789
6 · The paper itself

Abstract

HLA genes play a pivotal role in the immune response via presenting the pathogen peptides on the cell surface in a host organism. Here, we studied the association of HLA allele variants of class I (loci A, B, C) and class II (loci DRB1, DQB1, DPB1) genes with the outcome of COVID-19 infection. We performed high-resolution sequencing of class HLA I and class II genes based on the sample population of 157 patients who died from COVID-19 and 76 patients who survived despite severe symptoms. The results were further compared with HLA genotype frequencies in the control population represented by 475 people from the Russian population. Although the obtained data revealed no significant differences between the samples at a locus level, they allowed one to uncover a set of notable alleles potentially contributing to the COVID-19 outcome. Our results did not only confirm the previously discovered fatal role of age or association of DRB1*01:01:01G and DRB1*01:02:01G alleles with severe symptoms and survival, but also allowed us to single out the DQB1*05:03:01G allele and B*14:02:01G~C*08:02:01G haplotype, which were associated with survival. Our findings showed that not only separate allele, but also their haplotype, could serve as potential markers of COVID-19 outcome and be used during triage for hospital admission.

Indexed as

COVID-19Histocompatibility Antigens Class IHistocompatibility Antigens Class IIAllelesGene FrequencyHaplotypesHLA-DRB1 ChainsHumansRussiaHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-DRB1 ChainsCOVID-19 mortalitydiversity of HLA alleleshaplotype frequenciesHLA-typingimmunology

Identifiers

PMID36834479
PMCPMC9960097
OpenAlexW4319318630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.